BGP-15

CAS : 66611-37-8

Ref. 3D-RCA61137

Informations sur le produit

• Nom: BGP-15
• CAS: 66611-37-8

Description

BGP-15 is a mitochondria-targeted pharmacological agent that has been shown to improve cardiac function and reduce oxidative stress. BGP-15 is a peptide with reactive properties, which inhibits the production of reactive oxygen species (ROS) and increases mitochondrial membrane potential. These effects are mediated by activation of the cytochrome c oxidase pathway in the mitochondria, leading to increased energy metabolism and ATP production. BGP-15 has also been shown to reduce cardiomyocyte apoptosis and inhibit myocardial hypertrophy in vivo. The therapeutic potential of BGP-15 has been demonstrated in various models, including murine hepatoma cells, where it promotes caspase-independent cell death (apoptosis). This drug may have beneficial effects against infectious diseases such as tuberculosis or malaria, as well as autoimmune diseases such as rheumatoid arthritis.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 351.27 g/mol
• Formule: C₁₄H₂₄Cl₂N₄O₂
• Degré de pureté: Min. 95%